MedTrace Logo

2-HOBA: Multiple Dosing Study in Older Adults

NCT03556319 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2021-12-14

No results posted yet for this study

Summary

The purpose of this study is to test how well people tolerate a new dietary ingredient called 2-HOBA and how it is metabolized in the body. 2-HOBA is a compound that occurs naturally in buckwheat seeds. This dietary ingredient has been used in animal studies, and single doses have been tolerated well when given to a small group of healthy people. In this study we will test how well people tolerate taking 2-HOBA over 2 weeks and how it is metabolized by the body.

Conditions

  • Older Adults

Interventions

DIETARY_SUPPLEMENT

2-HOBA

2-HOBA is a compound found in buckwheat and is given as 2-HOBA acetate

DIETARY_SUPPLEMENT

Placebo

Placebo Comparator

Sponsors & Collaborators

  • Vanderbilt University

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • Metabolic Technologies Inc.

    lead INDUSTRY

Principal Investigators

  • John A Rathmacher, PhD · Metabolic Technologies Inc.

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-23
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03556319 on ClinicalTrials.gov